US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist
  • 1.6100
  • -0.0300-1.83%
Close Nov 29 13:00 ET
  • 1.6200
  • +0.0100+0.62%
Post 17:02 ET
105.46MMarket Cap-1578P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regulus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 0.000 --
-- 2024/Q4 -- / 0.000 --
-- 2024/Q3 0.000 / 0.000 --
-- 2024/Q2 0.000 / 0.000 --
-- 2024/Q1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Regulus Therapeutics Earnings Reports

  • Regulus Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:33

  • Regulus Therapeutics | 8-K: Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates

    Nov 8 05:22

  • Regulus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:30

  • Regulus Therapeutics | 8-K: Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates

    Aug 9 04:24

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data